Company Presentation • 15 May 2025 19:00
Company Presentation • 31 Jan 2024 20:00
Company Presentation • 28 Jun 2024 19:00
Company Presentation • 10 Apr 2025 19:00
Company Presentation • 13 Jan 2025 20:00
Search or
𝛼SK
𝛼SKENTITY
CureVac NV (CVAC US)
CureVac NV (CVAC US)
13
Analysis
Health Care • United States
CureVac N.V. operates as a global clinical-stage biopharmaceutical company. The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.
morex